In early 2024, the FDA approved continuous glucose monitoring devices for people without diabetes for the first time. It’s eminently understandable why people living with diabetes would need to keep a ...

DexCom has significant room to grow in its core market, despite disappointing results last year. One of Warren Buffett's ...

Diabetic nephropathy (DN) is a diabetes complication that comes from overactivation of Renin-Angiotensin System, excessive pro-inflammatory factors, reactive oxygen species (ROS) overproduction, and ...

Here's my watch telling me to try harder.Fifteen years ago, then-contributor Peter Lipson wrote a short post on this blog ...

Gestational Diabetes Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035 The report provides a detailed analysis of the current gestational diabetes ...

In this randomized clinical trial of adults with type 2 diabetes (T2D), the artificial intelligence-based insulin clinical ...

GlucoModicum today announced positive outcomes from a clinical performance study of its needle-free continuous glucose ...

Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor ...

The CGM is based on magnetohydrodynamic (MHD) technology, which non-invasively samples interstitial fluid, the body fluid ...

Managing type 2 diabetes in the first month can feel overwhelming, but focusing on key areas like education, monitoring, ...

In Q2 2025 Finland’s medicines agency, FIMEA, granted GlucoModicum authorization to initiate a new clinical investigation under Article 62 of the EU MDR (2017/745), enabling GlucoModicum to generate ...

By all means, if you’ve been told that exercise is non-negotiable for diabetes management, you’ve heard right. But what they ...